# Bramalea Partners

> Bramalea Partners is a VC fund in Boston backing Health Care and Software. See 12 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Boston, United States
- Total investments: 12
- Last investment: Mar 2026
- Lead investor: 8%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/bramalea-partners/
- Website: https://www.bramaleapartners.com/

Bramalea Partners is a VC fund in Boston focused on Health Care and Software. Bramalea Partners seeks for large, growing, well-established industries that are ripe for disruption via technology. Bramalea Partners provides expansion capital to help scale and grow a business that has a very large total addressable market that is easy to understand.

## Contacts

5 contacts available for Bramalea Partners. Shizune tracks 1 team members at Bramalea Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/bramalea-partners?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 33% |
| Software | 3 | 25% |
| Wellness | 3 | 25% |
| Fitness | 2 | 17% |
| Wearables | 2 | 17% |

36 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Venture - Series Unknown | 5 | 42% |
| Series B | 3 | 25% |
| Series C | 2 | 17% |
| Series A | 1 | 8% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Andrew Boyd | Founder | 3 | https://shizune.co/investors/profile/andrew-boyd-b959 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Condor Software | Financial management software for biopharma | $24M | Series A | Mar 18, 2026 |  |
| Tilt | TiLT is an information technology company that specializes in reimagining the employee leave management process. It focuses on the field of business development, employee benefits, and human resources. It was founded in 2017 and headquartered in Fort Collins, Colorado. | $15M | Series B | Aug 27, 2024 |  |
| Neurable | Neurable is a neurotechnology company specializing in developing AI-powered tools for brain signal translation and brain-computer interface technology. Utilizing patented signal processing, developed through research across labs and institutions, and advanced by a scientific and expert product team, its platform enables high-performancebrain-computer interface in everyday devices. | $13M | Venture - Series Unknown | May 07, 2024 |  |
| Luna | Physical therapy is powerful—for developing strength, managing emerging conditions, or recovering from surgery. But it’s challenging for physical therapy to make a significant clinical impact because therapists and patients are worn out.Traditional physical therapy leaves more than 50% of therapists suffering from work-related pain and 70% ofpatients failing to complete their course of care. On both sides of the therapy table, people need better support.At Luna, they’re designing a practice that gives therapists and patients the independence, control, and motivation they need to feel meaningful relief. |  | Series B | Jun 02, 2022 |  |
| Swiftly | Swiftly is the AI platform purpose-built for retail, serving retailers, wholesalers, and brands. Swiftly's AI agents unify data, automate workflows, and power the marketing that drives measurable growth — connecting shopper engagement, operations, and personalized experiences into one intelligent platform. Swiftly AI is built on theindustry's largest proprietary retail dataset: live transactions, 9 million products, and the closed-loop campaign outcomes of 33,000 stores. That foundation powers faster decisions, smarter execution, and AI-native experiences across the retail ecosystem. Trusted by leading retailers, wholesalers, and hundreds of iconic brands, Swiftly accelerates growth, reduces operational drag, and sets a new standard for what AI can do in retail. | $100M | Series B | Mar 08, 2022 |  |
| Swiftly | Swiftly is the AI platform purpose-built for retail, serving retailers, wholesalers, and brands. Swiftly's AI agents unify data, automate workflows, and power the marketing that drives measurable growth — connecting shopper engagement, operations, and personalized experiences into one intelligent platform. Swiftly AI is built on theindustry's largest proprietary retail dataset: live transactions, 9 million products, and the closed-loop campaign outcomes of 33,000 stores. That foundation powers faster decisions, smarter execution, and AI-native experiences across the retail ecosystem. Trusted by leading retailers, wholesalers, and hundreds of iconic brands, Swiftly accelerates growth, reduces operational drag, and sets a new standard for what AI can do in retail. | $100M | Series B | Mar 08, 2022 |  |
| Dragonfly Therapeutics | Dragonfly Therapeutics is a clinical-stage biotech developing novel first-in-class therapeutics targeted at natural killer cells and other cells of the innate immune system. These therapies are designed to counterbalance immune suppressive factors present in the tumor microenvironment and mobilize anti-cancer immune responses. Our molecules areexpected to be potent as single agents as well as in treatment combinations with existing cancer immunotherapies. Our scientific founders are major figures in cancer biology and immunology and have launched Dragonfly to harness the power of the immune system to provide breakthrough cancer treatments for patients. For more information, email info@dragonflytx.com. |  | Venture - Series Unknown | Jan 01, 2022 |  |
| Health IQ | Their mission: to increase health literacy around the worldOver the last 100 years, the world’s language literacy has increased significantly. Their challenge over the next 100 years is to increase the world’s health literacy. They believe the best way to create change is to celebrate the people who are dedicated to their health, rather thanharass the people who are not. The Health Conscious are the unsung heroes — the people who don’t get credit for their hard work. Help us spread health literacy to every corner of the world. |  | Venture - Series Unknown | Jan 01, 2022 |  |
| Skyhawk Therapeutics | Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.The company's therapeutics use proprietary technology that helps the rational design of small molecules that target specific binding pocket regions on RNA, using both sequence and structural specificity, at particularmoments in the RNA splicing process, enabling physicians to target diseases driven by a type of RNA mis-splicing called exon skipping. | $133M | Venture - Series Unknown | Sep 14, 2021 |  |
| Kindbody | Kindbody operates a health and tech company intended to offer fertility services and treatments for the modern woman. It offers a full range of services including intrauterine insemination, in-vitro fertilization, donor support, egg freezing, and embryo freezing, enabling women to improve their overall health and wellbeing. | $62M | Series C | Jun 25, 2021 |  |

10 of 12 investments shown.

## Co-investors
- [Gaingels](https://shizune.co/investors/profile/gaing) — VC Fund, 2 deals together
- [Insight Partners](https://shizune.co/investors/profile/insight-partners) — VC Fund, 2 deals together
- [Liquid 2 Ventures](https://shizune.co/investors/profile/liquid2-ventures) — VC Fund, 2 deals together
- [Martin Companies](https://shizune.co/investors/profile/martin-companies) — VC Fund, 2 deals together
- [PROOF](https://shizune.co/investors/profile/new-atlantic-ventures) — VC Fund, 2 deals together
- [Rock Springs Capital](https://shizune.co/investors/profile/rock-springs-capital) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund

## FAQ

### What does Bramalea Partners invest in?

Bramalea Partners invests primarily in Health Care, Software and Wellness startups, most often at Venture - Series Unknown and Series B stage. Most of the 12 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Bramalea Partners?

Public channels for Bramalea Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Bramalea Partners?

The team at Bramalea Partners includes Andrew Boyd (Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co